@medliveofficial.bsky.social
Education for healthcare providers, patients & caregivers. š©ŗšš©š»āāļøšØš½āāļø
Make informed health decisions based on the latest science.
Access Medlive here ā”ļø https://bit.ly/3QAXfVt
@medliveofficial.bsky.socialExplore how AI-driven coronary plaque analysis can identify high-risk CAD beyond stenosis severity and guide earlier preventive care through real-world imaging cases.
Watch now: vist.ly/5neda
@medliveofficial.bsky.socialMany patients with gMG still face residual symptoms and steroid burden. ā¶ļø Watch this on-demand program exploring treat-to-target care, patient goals, and emerging RNAi-based complement modulation.
Watch: vist.ly/5ndfk
@medliveofficial.bsky.socialClosing the mCSPC treatment intensification gap starts with informed decisions. Join this live program exploring doublet and triplet strategies, ARASEC findings, and real-world care.
ā¶ļø Register: vist.ly/5n863
@medliveofficial.bsky.socialIgAN treatment is evolving. Join experts live to explore updated KDIGO goals, terminal complement inhibition, and practical strategies for vaccination, REMS, and monitoring.
š
October 13, at 11:30am ET
ā¶ļø Register: vist.ly/5n7ch
@medliveofficial.bsky.socialProstate cancer care is evolving. ā¶ļø Watch this on-demand program exploring new disease terminology, earlier use of RLT, treatment sequencing, patient selection, and community implementation.
Watch now: vist.ly/5k7ju
@medliveofficial.bsky.socialHow can patients navigate real-world disruptions with once-weekly basal insulin? Explore strategies for missed doses, illness, fasting, travel, and maintaining glycemic stability.
ā¶ļø Access here: vist.ly/5jedu
@medliveofficial.bsky.socialHow can ADT strategies impact CV outcomes in prostate cancer? Explore case-based guidance on CV risk assessment, treatment selection, monitoring, and multidisciplinary care.
ā¶ļø Access on-demand: vist.ly/5hr45
@medliveofficial.bsky.socialExpanding cancer clinical trial access starts with community engagement. Explore practical strategies to identify eligible patients, address participation barriers, and support more equitable trial access.
ā¶ļø Access session 1 on-demand: bit.ly/4i4F9dM
@medliveofficial.bsky.socialThe burden of prurigo nodularis may be greater than it appears.
ā¶ļø Watch this on-demand activity for practical strategies on biologic therapy, patient communication, and shared decision making.
Watch: bit.ly/3UnQ6wY
